Brief: China Shineway Pharmaceutical says unit entered agreement to sell interests of Jing Li Yuan Biotechnology

China Shineway Pharmaceutical

04/07/2016 05:14

July 4 (Reuters) - China Shineway Pharmaceutical Group Ltd  2877.HK : 
 
 * The vendor, an indirect wholly- owned subsidiary of the company, and the purchaser entered into the agreement 
 * Purchaser agreed to acquire the entire equity interests of Jing Li Yuan 
 * Deal for consideration of RMB80 million 
 
* Source text for Eikon  ID:nHKS65cHFn  
 
* ((For more news, please click here  2877.HK ))  
  ((Bengaluru Newsroom; +91 80 6749 1130))